Paola Cudia

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score

Costanza Lamperti, Greta Fabbri, Liliana Vercelli et al. · Muscle & Nerve · 2010 · 151 citations · Full text

Muscle Function, Diagnosis, Orthopaedic Surgery +17

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 130 citations · Full text

Clinical Trials, Progressive Supranuclear Palsy, Placebo-controlled Trial +7

Identification of novel mutations in five patients with mitochondrial encephalomyopathy

Lucia Valente, Daniela Piga, Eleonora Lamantea et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 2008 · 101 citations

Mitochondrial Myopathy, Mendelian Disorder, Mitochondrial Function +8

Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables

Paola Cudia, Pia Bernasconi, Roberta Chiodelli et al. · Journal of Neurology Neurosurgery & Psychiatry · 2009 · 60 citations